The CBS Mornings host, 70, who recently vacationed with longtime friend Oprah Winfrey, 71, and Kardashian matriarch Kris, 69, ...

A new experimental drug meant to be taken just once a month could lead to “substantial weight reduction” within a year and help overcome both diabetes and obesity, a new clinical trial ...

“The data demonstrates the potential for once monthly or less frequent dosing and are particularly encouraging as we seek sustainable, long-term treatments for people living with obesity, with and ...

"In this Phase 2 study, participants living with obesity treated with MariTide had substantial weight reduction at 52 weeks without reaching a weight plateau," said Ania Jastreboff, professor at Yale ...

CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in patients with obesity with or without type 2 diabetes, a phase II randomized ...

"In this Phase 2 study, participants living with obesity treated with MariTide had substantial weight reduction at 52 weeks without reaching a weight plateau," said Ania Jastreboff, professor at ...

"Once-monthly treatment options for type 2 diabetes have long been sought after, yet elusive," said Ania M. Jastreboff, MD, PhD, professor at Yale School of Medicine (Endocrinology), director of ...

Ania Jastreboff, MD, PhD, associate professor of internal medicine and pediatrics at Yale University School of Medicine, New Haven, Connecticut, spoke remotely about the current pharmacological ...

News 8 sat down with Dr. Ania Jastreboff, a Yale associate professor, endocrinologist and obesity medicine physician, to discuss these weight loss drugs. She leads the Yale Obesity Research Center ...